Roche and Merck Collaborate to Develop Diagnostic Tests for Merck's Investigational Cancer Therapies

Merck MRK and Roche (RHHBY) today announced that they have entered into a collaboration focused on the application and development of diagnostic assays for use with Merck's investigational cancer therapy portfolio. Financial details were not disclosed.